PMNCH: Mandate, Structure, and Current Strategy

EXECUTIVE SUMMARY

The Partnership for Maternal, Newborn and Child Health (PMNCH) is the world's largest alliance dedicated to women's, children's, and adolescents' health, encompassing over 1,000 member organisations across eight formal constituency groups. Established in 2005 through the merger of three predecessor partnerships and hosted by WHO in Geneva, PMNCH occupies a structurally unusual position in the global health architecture: it is simultaneously a WHO-hosted interorganisational platform, a multi-stakeholder advocacy coalition, and a formal accountability mechanism for the Every Woman Every Child (EWEC) political movement. Its budget — estimated at USD 15–25 million per year in secretariat and programme expenditure — is modest relative to implementing agencies, but its convening reach and coalition breadth amplify influence far beyond what the budget figure suggests.

PMNCH's most distinctive institutional feature is its governance model. Unlike any UN agency, it formally enfranchises non-state actors — civil society, health professional associations, the private sector, and philanthropic foundations — in its board-level decision-making. This multi-stakeholder constitution makes PMNCH simultaneously more representative and more complex to govern than a standard intergovernmental body. The WHO Director-General serves nominally as Board Chair, but operational governance is managed through a professional secretariat of approximately 35–45 staff, supported by an elected Board in which all eight constituencies hold seats.

The 2021–2025 strategy — the fourth in PMNCH's history — is organised around three intersecting themes: equity (with particular attention to the most marginalised populations), accountability (strengthening the EWEC commitment-tracking mechanism), and innovation (scaling digital health approaches and new financing models). A notable expansion in the current strategy period is the deliberate integration of adolescent and youth voices into governance, operationalised through a structured Youth Engagement Initiative that gives young people formal advisory standing. PMNCH has also inserted climate and health into its strategic framework, acknowledging the growing evidence base linking climate change to adverse maternal, newborn, and child outcomes.

For decision-makers, the key frame for PMNCH is that it is a force multiplier, not a delivery mechanism. Its value is proportional to how well the global health community uses its convening authority, how rigorously it maintains its accountability function, and how effectively it translates its diverse membership into coherent political action. For practitioners, PMNCH is a knowledge and network resource — its publications and partner connections offer value, but it has no country-level operational function. Researchers will find it an interesting case study in multi-stakeholder governance, political accountability without enforcement, and the institutionalisation of global health norms.

KEY FACTS

PMNCH was established in 2005 through the merger of three predecessor partnerships: the Partnership for Safe Motherhood and Newborn Health, the Child Survival Partnership, and the Healthy Newborns Partnership.
It is hosted at WHO headquarters in Geneva, Switzerland; formal legal standing derives from the hosting agreement with WHO.
Membership exceeds 1,000 organisations across over 80 countries, making it the largest alliance dedicated to women's, children's, and adolescents' health.
Members are organised into eight formal constituency groups: governments (LMICs), donor governments, multilateral organisations, health professional associations, NGOs, academic/research institutions, private sector, and philanthropic foundations.
The WHO Director-General serves as nominal Board Chair; in practice, a senior WHO official or the elected Board Co-Chair presides over Board meetings.
The Board meets twice yearly and has approximately 30 members representing all eight constituencies.
The secretariat employs approximately 35–45 professional staff based at WHO Geneva; this is deliberately small relative to the scale of the membership.
Annual secretariat budget is estimated at approximately USD 15–25 million; the majority comes from a small group of bilateral donors (UK/FCDO, Sweden/Sida, Norway, Canada, Gates Foundation among the most consistent).
The 2021–2025 strategy is PMNCH's fourth strategic plan; previous strategy periods were 2009–2011, 2012–2016, and 2016–2020.
PMNCH convenes a Partner Forum every two years; Forums have been held in Beijing (2007), New Delhi (2010), Cape Town (2013), Johannesburg (2016), New Delhi (2018), virtually (2020–21 pandemic period), Dar es Salaam (2022), and most recently in 2024.
PMNCH is the primary accountability mechanism for the Every Woman Every Child (EWEC) movement, launched in 2010 by UN Secretary-General Ban Ki-moon and renewed with the Global Strategy 2016–2030.
Since EWEC's launch, the partnership has tracked over USD 60 billion in commitments from governments, multilaterals, civil society, and the private sector.
The Youth Engagement Initiative, formalised in the 2021–2025 strategy period, provides structured governance representation for young people under 25.
PMNCH's mandate has expanded progressively: from maternal and child health at founding, to include newborn health, adolescent health, SRHR, and now climate-health intersections.
PMNCH does not fund country programmes, procure health commodities, operate health facilities, or employ field or country staff.
The PMNCH secretariat reports annually to the Board on strategic plan implementation and financial performance; reports are publicly available.
PMNCH participates in the H6 coordination mechanism alongside WHO, UNICEF, UNFPA, UN Women, and the World Bank for UN system coordination on MNCH/SRHR.

BACKGROUND AND CONTEXT

The Gap PMNCH Was Created to Fill

In the early 2000s, global advocacy for maternal and child health was fragmented across three separate partnership platforms: one focused on safe motherhood and newborn health, one on child survival, and one on newborn health specifically. Each had its own secretariat, membership base, governance structure, and advocacy voice. This triplication of effort was widely recognised as inefficient — the fragmented voice weakened advocacy at a moment when political attention and financing for MNCH were critically needed.

The MDG framework (2000–2015) had set targets for maternal mortality reduction (MDG 5) and child mortality reduction (MDG 4) that the global community was already falling behind on. Progress was insufficient, and the advocacy infrastructure for these issues lacked the scale and coherence to generate the political pressure needed to accelerate it.

The 2005 merger created PMNCH as a single, unified platform. The logic was coalition theory: a broad, credible alliance of diverse actors speaking with a shared voice carries more political weight than multiple smaller voices. By combining the constituencies, reach, and reputations of the three predecessor partnerships, PMNCH immediately became the largest alliance in the global MNCH space.

WHO hosting was the institutional mechanism that gave PMNCH legitimacy and legal standing without requiring it to be a new UN agency. WHO provided office space, administrative infrastructure, and association with the WHO brand — but PMNCH was explicitly designed not to be a WHO programme. It has its own governance, its own strategic plan, and its own identity. The hosting relationship is an enabling framework, not a subordinate relationship.

The MDG Era and PMNCH's First Decade

PMNCH's first decade coincided with the final years of the MDG era. In this period, PMNCH's primary advocacy function was generating political and financial momentum for MDG 4 and 5 — reducing child and maternal mortality. The partnership worked to mobilise donor government investments, push LMIC governments to increase domestic health financing, and build the coalition of implementing actors working on the same goals.

The launch of Every Woman Every Child in September 2010 at the MDG Summit was a defining moment for PMNCH. EWEC — initiated by UN Secretary-General Ban Ki-moon — created a political framework for mobilising commitments, and PMNCH was designated as the accountability mechanism. This gave PMNCH a structured, high-visibility role that distinguished it from a purely advocacy body: it would now formally track whether the commitments that governments and other actors made were actually delivered.

Between 2010 and 2015, PMNCH published annual progress reports on EWEC commitments. This accountability function became the organisation's most distinctive contribution to global health governance — no other body was systematically tracking MNCH/SRHR commitments across such a broad set of stakeholders and publishing the results publicly.

The SDG Transition (2015–Present)

The transition from MDGs to SDGs in 2015–2016 required PMNCH to update its framing. The Global Strategy for Women's, Children's and Adolescents' Health 2016–2030 (the "EWEC 2.0" framework) expanded the scope from MDG 4 and 5 targets to the full SDG 3 ambitions for women's, children's, and adolescents' health. Three "ends" were defined: Survive (ending preventable deaths), Thrive (ensuring health and well-being), and Transform (expanding enabling environments).

PMNCH's mandate expanded correspondingly. The addition of "adolescents" to the 2016–2030 Global Strategy brought PMNCH more explicitly into the SRHR space — adolescent sexual and reproductive health is a core component of the adolescent health agenda. This expansion brought PMNCH's mandate closer to UNFPA's core territory, creating more overlap but also more potential for joint advocacy.

ORGANISATIONAL DETAIL

The Eight-Constituency Governance Model

The eight-constituency structure is PMNCH's foundational organisational innovation. It operationalises multi-stakeholder governance in a way that no UN agency can replicate: formal board-level representation for non-state actors including civil society, health professionals, the private sector, and philanthropies.

Governments (LMICs): Low- and middle-income country governments form one constituency. Their representation on the Board gives implementing country perspectives formal standing — not just as recipients of aid but as governance participants.

Donor Governments: High-income country governments that finance global health form a separate constituency. The separation of LMIC and donor governments is significant — it prevents donor voice from overwhelming recipient-country perspectives.

Multilateral Organisations: WHO, UNICEF, UNFPA, the World Bank, and similar bodies are represented here. UNFPA's Board membership in the multilateral constituency means it is simultaneously a PMNCH governance actor and a member organisation subject to PMNCH's accountability mechanism.

Health Professional Associations: This constituency — including FIGO (International Federation of Gynecology and Obstetrics), ICM (International Confederation of Midwives), and the International Pediatric Association — is one of PMNCH's most distinctive features. Clinical professional bodies rarely have formal governance roles in global health platforms. PMNCH's inclusion of them creates a direct channel between clinical evidence and global health policy.

NGOs: International and national NGOs working on MNCH/SRHR. This constituency is large and diverse, ranging from large international NGOs (Save the Children, Marie Stopes International, Plan International) to national organisations in LMICs.

Academic and Research Institutions: Universities, research networks, and think tanks with relevant expertise. This constituency supports PMNCH's evidence function and connects it to the global health research community.

Private Sector: Companies with relevant health-sector interests — pharmaceutical manufacturers, medical device companies, health technology companies. Private sector inclusion in governance is rare in global health and remains contested (see Key Debates section).

Philanthropic Foundations: The Gates Foundation is the most prominent, but other foundations with MNCH/SRHR portfolios are included. The philanthropy constituency provides access to significant non-governmental financing and to the agenda-setting influence large foundations exercise in global health.

How the Board Functions

The Board meets twice annually — typically at the World Health Assembly session in May and at a second session later in the year. Between Board meetings, a smaller Executive Committee handles urgent governance matters.

Board decision-making operates by consensus where possible and by majority vote where necessary. The requirement to represent all eight constituencies creates governance complexity: reaching consensus across governments, NGOs, health professionals, private sector, and philanthropy on contested issues (particularly SRHR and rights-based approaches) can be difficult. PMNCH has developed procedural mechanisms for managing these tensions, but political divisions within the Board are real and can constrain the partnership's advocacy on the most politically sensitive issues.

The WHO Director-General's nominal chairpersonship creates a formal link to WHO leadership but also a structural ambiguity: WHO is simultaneously a PMNCH partner, the host organisation, and the body whose DG chairs the Board. In practice, a civil society or government Co-Chair often provides more active Board leadership on day-to-day governance.

The Secretariat

The secretariat is small by design — 35–45 professional staff, most based in Geneva at WHO. The model is deliberate: PMNCH leverages the capacity of its 1,000+ partner organisations rather than building a large internal bureaucracy. The secretariat functions include:

Strategic planning and management: Developing and managing the multi-year strategic plan; coordinating cross-thematic programming.
Partner engagement and network management: Maintaining relationships with 1,000+ partners; managing constituency coordination; running the partner database.
Research and evidence work: Commissioning and producing knowledge products (see PMNCH-W-01 for detail).
Accountability tracking: Managing the EWEC commitment database; producing annual progress reports.
Communications and publications: Managing external communications, website, and publications.
Events management: Planning and running the biennial Partner Forum and events around major global health moments.

The small secretariat creates efficiency and cost advantages but also creates dependencies: if core secretariat staff turn over, institutional knowledge and relationship capital are at risk. PMNCH has experienced periods where leadership transitions have created strategic uncertainty.

Leadership and Accountability Within the Organisation

The Executive Director of PMNCH — appointed by the Board — is responsible for day-to-day management and reports to the Board. The Board holds the Executive Director accountable through annual performance reviews, budget oversight, and strategic plan monitoring.

PMNCH undergoes periodic external evaluations — typically commissioned by the major donor governments (UK, Sweden, Norway). These evaluations assess whether the secretariat is delivering against the strategic plan, whether the partnership model is working, and whether the investment represents value for money. The most recent public evaluation findings (available to 2020–21) identified PMNCH's accountability function and convening capacity as its strongest contributions, while noting persistent challenges in demonstrating outcome-level impact.

Partner Forums

The biennial Partner Forum is PMNCH's highest-visibility event. It serves multiple purposes simultaneously: it is an evidence showcase, an advocacy moment, a networking opportunity, a commitment-generation platform, and a media event. Forums are deliberately timed to align with or precede major political milestones.

Key Forums by impact: the 2010 New Delhi Forum aligned with EWEC's launch and the MDG Summit; the 2018 New Delhi Forum aligned with the ICPD+25 preparatory process and helped build momentum toward the 2019 Nairobi Summit; the 2022 Dar es Salaam Forum marked PMNCH's return to in-person convening after COVID and generated significant new commitments to equity in MNCH/SRHR. The 2024 Forum continued this trajectory.

KNOWLEDGE PRODUCTS AND OUTPUTS

PMNCH's knowledge function is primarily one of synthesis and translation, not original research production. Its main output categories are:

The "What Works for Women and Children" Series: PMNCH's flagship evidence product. Each volume is a commissioned systematic review of evidence on a specific MNCH/SRHR topic. Topics addressed include: stillbirth prevention, adolescent health interventions, community health worker programmes, sexual violence prevention, maternal nutrition, health systems strengthening, newborn health care practices, skilled birth attendance, and family planning. The series is peer-reviewed, publicly available, and published in accessible formats alongside academic papers. Quality is generally high — the reviews use rigorous methodology and are transparent about evidence strength. The main limitation is coverage: the series cannot keep pace with the full range of evidence questions relevant to PMNCH's mandate.

EWEC Progress Reports (Annual): These are simultaneously accountability tools and knowledge products. Each annual report includes global trend data on MNCH/SRHR indicators, synthesis of commitment-holder progress reports, and thematic feature sections aligned with that year's advocacy priorities. They are PMNCH's most widely read publications and serve as the reference document for the EWEC accountability mechanism.

Policy Briefs: Shorter (typically 4–8 page) documents translating specific evidence findings for targeted policy audiences. Produced in response to specific policy moments — ahead of conferences, in support of advocacy campaigns, or to address emerging debates.

Countdown to 2030 Partnership: PMNCH is a co-publisher and convener of Countdown to 2030, the leading academic tracking initiative for coverage of interventions for women's, children's, and adolescents' health. Countdown produces country-specific data on intervention coverage that is widely used by governments and donors. PMNCH's connection to Countdown gives it access to and credibility with the academic epidemiological community.

Working Group Publications: PMNCH's thematic working groups produce joint publications, case study compilations, and advocacy materials. Quality varies by working group and depends heavily on the expertise of member organisations engaged.

THE ACCOUNTABILITY FUNCTION: WHAT IT DELIVERS AND WHERE IT FALLS SHORT

See PMNCH-W-02 for a full analysis. In brief: PMNCH's accountability function through EWEC commitment tracking is the partnership's most distinctive contribution to global health governance. It has demonstrably mobilised political attention and significant financial resources. However, the mechanism relies on self-reported data, has no enforcement power, and cannot attribute changes in health outcomes to the commitment framework itself. Independent evaluations consistently identify it as effective political accountability (holding actors publicly to their stated commitments) but insufficient as a rigorous evaluation of whether PMNCH's work improves health outcomes at scale.

FUNDING, SCALE AND RESOURCES

PMNCH's secretariat budget — approximately USD 15–25 million per year — is small compared to implementing agencies but substantial for a convening platform. For comparison, Gavi (the Vaccine Alliance) disburses over USD 1.5 billion per year; the Global Fund disburses approximately USD 4 billion per year; UNFPA's programme expenditure is approximately USD 1 billion per year. PMNCH's budget is not comparable to these figures because it does not disburse grants or run country programmes — its expenditure is almost entirely secretariat and programme costs.

The donor base is narrow: a small number of bilateral donors (UK/FCDO, Sweden/Sida, Norway/Norad, Canada/Global Affairs, and occasionally others) provide the majority of core funding, alongside the Gates Foundation. This concentration creates financial vulnerability — a shift in any one major donor's priorities can substantially affect PMNCH's budget.

The WHO hosting relationship provides significant in-kind support: office space, administrative infrastructure, legal standing, and association with WHO's convening authority. The value of this in-kind contribution is not typically monetised in PMNCH's budget figures.

Value-for-money analysis of PMNCH is structurally difficult because its outputs (convening, advocacy, accountability) do not lend themselves to the input-output ratios applicable to service delivery organisations. Independent evaluations typically assess value through a portfolio lens: does the scale of political mobilisation and financial commitment PMNCH generates justify its secretariat cost? On this framing, the answer from available evaluations is generally yes — the USD 60 billion+ in EWEC commitments mobilised since 2010, even heavily discounted for self-reporting and attribution problems, represents significant leverage on a modest secretariat investment.

KEY DEBATES AND CONTESTED QUESTIONS

Does PMNCH add value beyond its member organisations? The most fundamental question about any convening platform is whether the whole is greater than the sum of its parts. Sceptics argue that PMNCH's member organisations — WHO, UNICEF, UNFPA, major NGOs, bilateral donors — already coordinate through multiple mechanisms (H6, UNGA side events, bilateral relationships), and that PMNCH imposes coordination costs without adding proportionate value. Defenders argue that PMNCH provides a uniquely structured platform that includes constituencies (private sector, health professionals, philanthropy) that UN-to-UN coordination mechanisms do not include, and that the EWEC accountability mechanism has no equivalent elsewhere.

Is the private sector in governance appropriate? PMNCH's inclusion of the private sector as a formal governance constituency is the most contested feature of its model. Civil society members within the partnership have at times argued that private sector representation conflicts with PMNCH's public health mission — particularly in relation to pharmaceutical pricing, health commodities access, and the marketing of health products to vulnerable populations. PMNCH's governance manages this tension through constituency separation (private sector representatives cannot vote on matters directly affecting their commercial interests), but the tension is structural and unresolved.

Is self-reported commitment tracking a meaningful accountability mechanism? Academic critics of the EWEC model note that self-reported commitment progress data is not reliable evidence of impact. A commitment holder can report that a commitment is "on track" based on inputs mobilised (money spent, people trained) rather than outcomes achieved (mortality reduced, contraceptive prevalence increased). PMNCH acknowledges this limitation and has gradually strengthened its commitment acceptance criteria, but the fundamental problem — that PMNCH lacks the capacity or mandate to independently verify most commitments — remains.

Does mandate expansion dilute PMNCH's focus? PMNCH's progressive expansion from MNCH to include SRHR, adolescents, and climate creates both opportunities and risks. Broader scope increases PMNCH's relevance and the size of its potential coalition. But it also potentially spreads a small secretariat too thin, creates more governance complexity (SRHR and climate are more politically contested than core child health), and risks duplicating functions that other organisations — UNFPA on SRHR, WHO on climate and health — are better placed to lead.

Does geographic unevenness limit PMNCH's effectiveness? PMNCH's membership includes over 1,000 organisations, but the distribution is heavily weighted toward organisations headquartered in high-income countries and toward international NGOs rather than LMIC civil society and government organisations. This creates a risk that PMNCH's advocacy priorities and knowledge products reflect the preoccupations of global health institutions rather than the priorities of the communities most affected by poor MNCH/SRHR outcomes.

COMPARISON WITH OTHER GLOBAL HEALTH PLATFORMS

PMNCH is most usefully compared to other multi-stakeholder partnership platforms rather than to funding or implementing bodies:

Stop TB Partnership (hosted by UNOPS): Similar hosting model, multi-stakeholder membership, advocacy and accountability functions. Difference: Stop TB also coordinates funding and technical assistance flows in ways PMNCH does not. Narrower disease focus enables more specific accountability.

Roll Back Malaria Partnership (hosted by WHO until 2016, now independent): Closest structural analogue. Also a WHO-hosted multi-stakeholder alliance for a specific health area. Roll Back Malaria similarly struggled with attribution of health outcomes to the partnership vs. individual member activities.

Global Fund to Fight AIDS, Tuberculosis and Malaria: Not a convening platform — a financing mechanism. The contrast illustrates PMNCH's model: where the Global Fund converts political will into direct grants to country programmes, PMNCH converts political will into commitments and accountability pressure. The Global Fund's impact is more attributable but its governance is also more narrowly focused on financial management.

Gavi, the Vaccine Alliance: Another financing mechanism, not a convening platform. Gavi's public-private partnership model has influenced thinking about PMNCH's private sector engagement, but Gavi's mandate (vaccine access) is far narrower than PMNCH's.

H6 Mechanism: Not a formal partnership but a coordination body for six UN agencies (WHO, UNICEF, UNFPA, UNAIDS, UN Women, World Bank). Illustrates the difference between UN-to-UN coordination and PMNCH's inclusive model.

The closest comparator for PMNCH's specific combination of multi-stakeholder governance, advocacy, accountability, and knowledge functions is probably the Global Health Security Agenda — a multi-government initiative for pandemic preparedness — though PMNCH's explicit inclusion of non-state actors in governance is more developed.

IMPLICATIONS BY AUDIENCE

For Practitioners and Programme Staff

PMNCH is not your implementing partner. It will not fund your programme, provide technical assistance in your country, or respond to your operational needs. What it offers practitioners is: (1) access to systematically synthesised global evidence through its "What Works" series and knowledge products; (2) connection to the global network of organisations working on the same issues; (3) a potential platform for amplifying local evidence or advocacy into global spaces; and (4) the EWEC commitment framework if your organisation wants to formally signal its commitments to MNCH/SRHR goals.

Engaging PMNCH practically means: subscribing to PMNCH publications and progress reports; checking the PMNCH partner database when seeking organisations working on specific topics; considering whether your organisation's work should be registered as an EWEC commitment; and, if relevant, participating in PMNCH working groups on thematic issues of interest.

The biennial Partner Forum is worth attending if your work has global advocacy dimensions — it is the largest convening of MNCH/SRHR actors anywhere, and the networking value is substantial. But attending a Partner Forum will not substitute for country-level engagement with governments, ministries of health, or operational implementing partners.

For Decision-Makers and Funders

The core question for funders is whether PMNCH's secretariat cost ($15–25 million/year) represents good value for what it delivers. The available evidence suggests a qualified yes, but with important caveats. PMNCH's leverage on its budget — in terms of the scale of commitments it mobilises and the coalition breadth it maintains — is real. The EWEC accountability mechanism has no direct equivalent. The multi-stakeholder governance model creates a space for political action that UN-only coordination mechanisms cannot replicate.

The caveats are significant. PMNCH's impact is not independently attributable — there is no credible counterfactual for what MNCH/SRHR outcomes would look like without PMNCH. The self-reported accountability mechanism systematically overstates commitment fulfilment. The narrow donor base creates financial fragility. And PMNCH's operational model depends on member organisations to deliver results that PMNCH claims credit for catalysing.

Funders considering engagement should assess: (1) whether PMNCH's current strategic priorities align with their own programmatic priorities; (2) whether the accountability mechanism they are supporting is being strengthened or remains in its current limited form; (3) what governance access PMNCH membership provides relative to its cost; and (4) how PMNCH engagement fits within a broader portfolio of global health investments.

For Researchers

PMNCH is an underexplored subject for academic research in global health governance, political economy, and accountability. Key research gaps include: rigorous evaluation of whether EWEC commitment tracking actually changes the behaviour of commitment holders; comparative analysis of PMNCH's multi-stakeholder model against similar platforms; and longitudinal analysis of PMNCH's influence on global health policy outcomes.

For researchers using PMNCH knowledge products: the "What Works" series is a credible evidence synthesis resource but should be treated as a secondary synthesis, not primary evidence. The annual EWEC Progress Reports are valuable for longitudinal tracking of commitment-making and self-reported progress, but the self-reported nature of the data requires careful handling. For health outcome data, PMNCH's reports should be cross-referenced with Countdown to 2030, WHO Global Health Observatory, and UNICEF/MICS data.

PMNCH's governance model offers rich material for scholars of multi-stakeholder governance, global health diplomacy, and the political economy of health financing. Its accountability mechanism is a case study in soft power and reputational governance — a form of accountability without enforcement that has theoretical and practical implications for global governance design.

CURRENT STATUS AND FUTURE DIRECTIONS

PMNCH is in the final phase of its 2021–2025 strategy. The 2024 Partner Forum — held as the world approached the midpoint of the SDG decade — was an important convening moment and a platform for assessing progress against EWEC and SDG 3 commitments. At the time of writing (early 2026), PMNCH will be in the process of developing its next strategic framework for 2026–2030, which will need to address the significant mid-decade gap on SDG 3 targets (maternal mortality, under-5 mortality, and adolescent health targets are all behind trajectory), the deepening climate-health nexus, and the persistent equity challenges that have widened in the wake of COVID-19.

The next strategy will likely need to confront harder questions about PMNCH's accountability function: whether the self-reported commitment model can be strengthened to be more credible, and whether PMNCH should invest in independent verification capacity. The question of mandate scope — whether to consolidate or continue expanding — will also need resolution. And the financial model will need to be examined in the context of constraints on bilateral aid budgets in major donor countries.

PMNCH's institutional durability over 20 years reflects the genuine demand among global health actors for a broad coalition platform on MNCH/SRHR. The challenge for the next strategy period is ensuring that durability translates into accelerated health outcomes, not just institutional continuity.

SOURCES

PMNCH Strategic Plan 2021–2025. Geneva: WHO/PMNCH, 2021. Available at who.int/pmnch. Describes the three strategic themes (equity, accountability, innovation) and the Youth Engagement Initiative.
PMNCH Annual Reports (2010–2024). Geneva: WHO/PMNCH. Published annually; covers secretariat activities, financial performance, and partnership highlights.
Every Woman Every Child: Global Strategy for Women's, Children's and Adolescents' Health 2016–2030. New York: United Nations, 2015. The normative framework for PMNCH's accountability function.
Countdown to 2030 collaboration publications. Lancet and companion journals; PMNCH is a co-publisher. Provides the epidemiological backbone for PMNCH's health outcome reporting.
Shiffman J, Smith S. "Generation of political priority for global health initiatives: a framework and case study of maternal mortality." Lancet 2007; 370(9595):1370–79. Provides the academic framework for understanding PMNCH's advocacy function.
Sridhar D, Gostin LO. "Reforming the World Health Organization." JAMA 2011; 305(15):1585–86. Context for the WHO-hosting relationship and the politics of WHO-affiliated partnerships.
Storeng KT, Mishra A. "The PMNCH and the politics of global health coalitions." Global Public Health, 2014. Academic analysis of PMNCH's governance model and political dynamics.
UN Secretary-General. "Every Woman Every Child: Saving the lives of women and children." 2010. The founding political document for EWEC and PMNCH's accountability function.
Independent Evaluation of PMNCH (most recent; commissioned by donor governments). Available through PMNCH secretariat. Provides the most rigorous external assessment of PMNCH's performance.